NCT01747356View on ClinicalTrials.gov

Efficacy and Safety of RESOLUTE Zotarolimus-Eluting Stent in Treatment of Chinese Diabetic Coronary Lesions

NACompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Coronary Artery DiseaseDiabetes
Interventions
DEVICE

Resolute stent treatment

A well known coronary stent system that is produced by Medtronic Company and is also recommended by FDA for treating diabetic coronary lesion.

Trial Locations (1)

200025

Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT01747356 - Efficacy and Safety of RESOLUTE Zotarolimus-Eluting Stent in Treatment of Chinese Diabetic Coronary Lesions | Biotech Hunter | Biotech Hunter